Los Angeles, CA—Health Canada has granted a new set of health claims for Ixoreal Biomed‘s KSM-66 Ashwagandha root extract ingredient. The company announced that, under Health Canada’s NPN (Natural Product Number) 80102381 and its accompanying license, formulators using KSM-66 can make new claims related to memory enhancement, sleep, energy, stress, libido, testosterone and thyroid function.
With these latest approvals, Health Canada has now approved KSM-66 for a total of 14 claims, according to a press release from Ixoreal. Issuance of an NPN means the governmental regulatory body in Canada has reviewed the ingredient and its clinical evidence, and determined it be safe, effective, and of high quality under their recommended conditions of use, the release explains. Information on the clinical science supporting KSM-66 is available here.
“We are very pleased with these new set of claims,” said Kartikeya Baldwa, CEO at KSM-66 Ashwagandha. “These health claims are a testament to high-quality clinical research backing KSM-66, which Health Canada has recognized. We thank our partner CK Nutraceuticals for their continued strong performance in the Canadian market with respect to KSM-66’s market development.”
Related: Study: KSM-66 Ashwagandha a Safe, Effective Solution to Insomnia
Herb of the Month: Ashwagandha
Adaptogens: Nature’s Answer to Stressed & Tired
Baldwa added, “Because KSM-66 uses only the root and no other part of the ashwagandha plant, and because Health Canada’s own ashwagandha monograph similarly specifies only the root, these claims are over and above what is available to formulators who reference the generic Health Canada ashwagandha monograph.”